Pro Share Advisors LLC Oric Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$8.04 - $16.03 $94,333 - $188,079	11,733 New	11,733 $161,000
Q1 2022 May 10, 2022	SELL	$4.54 - $16.1 $56,509 - $200,396	-12,447 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$12.01 - $20.3 $24 - $40	-2 Reduced 0.02%	12,447 $184,000
Q3 2021 Nov 12, 2021	SELL	$15.9 - $25.22 $29,717 - $47,136	-1,869 Reduced 13.05%	12,449 $260,000
Q2 2021 Aug 13, 2021	BUY	$17.37 - $25.34 $55,358 - $80,758	3,187 Added 28.63%	14,318 $253,000
Q1 2021 May 14, 2021	BUY	$23.67 - $36.85 $13,302 - $20,709	562 Added 5.32%	11,131 $273,000
Q4 2020 Feb 09, 2021	BUY	$20.32 - $39.8 $214,762 - $420,646	10,569 New	10,569 $358,000

112

63.1M

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.